Regeneron Confirms that REGN-COV2 Antibody Cocktail Provided to President Trump Under Compassionate Use Request
October 2, 2020 --  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today confirmed that, as announced by the White House Press Secretary, Regeneron provided a single 8 gram dose of REGN-COV2, a cocktail of two monoclonal antibodies, for use by... (Source: - Clinical Trials)
Source: - Clinical Trials - October 2, 2020 Category: Pharmaceuticals Source Type: clinical trials

Trump administration unveils four executive orders aimed at lowering drug prices
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - July 25, 2020 Category: Cancer & Oncology Source Type: clinical trials

Caribbean Island Urinary Iodine Survey 2018
Condition:   Iodine Status (Deficiency / Excess) Intervention:   Sponsors:   Swiss Federal Institute of Technology;   Pan American Health Organization, Washington, D.C. 20037 USA;   Northwestern University, Potchefstroom, South Africa;   United Nations Children's Fund, New York, USA Completed (Source:
Source: - May 14, 2020 Category: Research Source Type: clinical trials